Literature DB >> 3350047

Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

R A Lyon1, M Titeler, M R Seggel, R A Glennon.   

Abstract

Twenty-one indolealkylamines, some of which are known to be psychoactive in man, were examined for their binding interactions with rat brain cortical 5-HT2 receptors labeled with the antagonist radioligand [3H]ketanserin in order to develop structure-activity relationships for binding at these sites. Features investigated included aromatic, alpha-methyl and terminal amine substituents. 4-Methoxy and 5-methoxy substitution impart a higher affinity than 6- or 7-methoxy substitution; a 7-hydroxyl group essentially abolishes affinity whereas a 7-methyl or 7-bromo group enhances affinity. alpha-Methylation has little effect on affinity and, in the one case examined, the S(+) isomer of alpha-methyltryptamine was essentially equipotent with its racemate and twice as potent as its R(-) enantiomer. Terminal amine methylation results in a small but progressive decrease in affinity in the order: primary amine greater than dimethylamine greater than diethylamine. Similarities were noted between these structural requirements for binding and those of the phenalkylamines. Selected compounds (5-methoxytryptamine, N,N-dimethyltryptamine, 5-methoxy-N,N-diethyltryptamine and 5-methoxy-N,N-dimethyltryptamine) were further examined by two-site analysis of displacement studies for [3H]ketanserin specific binding. Hill coefficients were significantly less than unity and computer-assisted analysis indicated that a two-site model better fit the data than a one-site model. In displacement studies using the putative agonist radioligand [3H]DOB to label 5-HT2 receptors affinities were 10-100-fold higher than those using [3H]ketanserin. These results are also consistent with earlier findings using psychoactive phenalkylamines in competition studies for radiolabelled 5-HT2 receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350047     DOI: 10.1016/0014-2999(88)90432-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.

Authors:  P A Pierce; J Y Kim; S J Peroutka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

2.  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

Authors:  Richard A Glennon
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

3.  Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.

Authors:  S M Mittman; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.

Authors:  B Sadzot; J M Baraban; R A Glennon; R A Lyon; S Leonhardt; C R Jan; M Titeler
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).

Authors:  W Dimpfel; M Spüler; D E Nichols
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.

Authors:  Michael B Gatch; Margaret A Rutledge; Theresa Carbonaro; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

Review 7.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

Review 8.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

9.  The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.

Authors:  H Y Meltzer; M Maes; M A Lee
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 10.  Clinical features and management of intoxication due to hallucinogenic drugs.

Authors:  J B Leikin; A J Krantz; M Zell-Kanter; R L Barkin; D O Hryhorczuk
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.